H. A. Fine

795 total citations
6 papers, 580 citations indexed

About

H. A. Fine is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, H. A. Fine has authored 6 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Cancer Research. Recurrent topics in H. A. Fine's work include Glioma Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (2 papers) and Neuroblastoma Research and Treatments (1 paper). H. A. Fine is often cited by papers focused on Glioma Diagnosis and Treatment (5 papers), Brain Metastases and Treatment (2 papers) and Neuroblastoma Research and Treatments (1 paper). H. A. Fine collaborates with scholars based in United States and Canada. H. A. Fine's co-authors include Kathleen R. Lamborn, Minesh P. Mehta, Lisa M. DeAngelis, Michael D. Prados, Fábio M. Iwamoto, Joohee Sul, Joanna H. Shih, Nicholas Butowski, Wei Zhang and H. I. Robins and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Neuro-Oncology and Current Oncology Reports.

In The Last Decade

H. A. Fine

6 papers receiving 570 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. A. Fine United States	5	421	236	174	145	144	6	580
Michael Badruddoja United States	8	387 0.9×	238 1.0×	160 0.9×	167 1.2×	152 1.1×	20	681
G. Dresemann Germany	7	417 1.0×	227 1.0×	157 0.9×	126 0.9×	142 1.0×	15	619
T. Mikkelsen United States	11	515 1.2×	270 1.1×	205 1.2×	134 0.9×	220 1.5×	21	731
Debra C. LaFrankie United States	10	537 1.3×	200 0.8×	180 1.0×	120 0.8×	201 1.4×	19	701
Benedikte Hasselbalch Denmark	9	399 0.9×	156 0.7×	151 0.9×	90 0.6×	136 0.9×	22	491
Ivan Lolli Italy	13	388 0.9×	158 0.7×	202 1.2×	190 1.3×	197 1.4×	40	672
Emese Filka United States	6	533 1.3×	240 1.0×	197 1.1×	128 0.9×	202 1.4×	9	672
Macarena I. de la Fuente United States	13	300 0.7×	153 0.6×	106 0.6×	122 0.8×	79 0.5×	36	510
Roxanne Marshall United States	5	265 0.6×	199 0.8×	152 0.9×	87 0.6×	87 0.6×	6	433
Simona Rizzato Italy	10	300 0.7×	128 0.5×	133 0.8×	139 1.0×	148 1.0×	24	448

Countries citing papers authored by H. A. Fine

Since Specialization

Citations

This map shows the geographic impact of H. A. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. A. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. A. Fine more than expected).

Fields of papers citing papers by H. A. Fine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. A. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. A. Fine. The network helps show where H. A. Fine may publish in the future.

Co-authorship network of co-authors of H. A. Fine

This figure shows the co-authorship network connecting the top 25 collaborators of H. A. Fine. A scholar is included among the top collaborators of H. A. Fine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. A. Fine. H. A. Fine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Fine, H. A., et al.. (2024). Integrative Geriatric Oncology: A Review of Current Practices. Current Oncology Reports. 26(10). 1146–1158. 1 indexed citations

2.

McNeill, K., et al.. (2012). A phase I/II trial of vandetanib for patients with recurrent malignant glioma. Neuro-Oncology. 14(12). 1519–1526. 65 indexed citations

3.

Kreisl, Teri, Wei Zhang, Yazmín Odia, et al.. (2011). A phase II trial of single-agent bevacizumab in patients with recurrent anaplastic glioma. Neuro-Oncology. 13(10). 1143–1150. 90 indexed citations

4.

Iwamoto, Fábio M., Kathleen R. Lamborn, H. I. Robins, et al.. (2010). Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02). Neuro-Oncology. 12(8). 855–861. 166 indexed citations

5.

Raizer, Jeffery J., L. E. Abrey, Andrew B. Lassman, et al.. (2009). A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro-Oncology. 12(1). 95–103. 221 indexed citations

6.

Peng, Tien, Xing‐Jie Liang, Oluwaseun Akeju, et al.. (2007). The 1p-Encoded Protein Stathmin and Resistance of Malignant Gliomas to Nitrosoureas. JNCI Journal of the National Cancer Institute. 99(8). 639–652. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact